FDA Inspection 883474 — New York Blood Center, Inc.

New York Blood Center, Inc. — FEI 3002663381

The FDA completed an inspection of New York Blood Center, Inc. on Jun 24, 2014 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 24, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)